Placebo News and Research

RSS

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Bochum-based psychologists have studied how the application of the stress hormone cortisol affects exposure therapy for anxiety disorders.

25 Apr 2019

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

Researchers at University of California San Diego School of Medicine found that using blood thinners in patients with worsening heart failure, coronary artery disease or irregular heart rhythms was associated with a 17 percent reduced risk of thromboembolic events, such as stroke and heart attack.

25 Apr 2019

FDA authorizes marketing of first medical device to treat ADHD

The U.S. Food and Drug Administration today permitted marketing of the first medical device to treat attention deficit hyperactivity disorder.

22 Apr 2019

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

The commonly used diabetes drug metformin could reverse the harmful thickening of heart muscle that leads to cardiovascular disease, according to a study at the University of Dundee.

17 Apr 2019

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

"Magic mouthwash," an oral rinse containing diphenhydramine, lidocaine and antacids, significantly reduced pain from oral mucositis, mouth sores, in patients receiving radiation therapy for cancers of the head and neck when compared to plaecbo.

16 Apr 2019

Drug lowers kidney failure risk in diabetic patients, study finds

A new landmark clinical trial shows that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.

15 Apr 2019

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks.

15 Apr 2019

Brain training to strengthen the brain's neural network

A new study reveals that less than an hour of training the brain could help strengthen the neural connections of the brain. This study could help develop new treatment and management strategies for progressive neurodegenerative disorders such as stroke and Parkinson’s believe the researchers.

15 Apr 2019

Less than one hour of brain training leads to strengthening of neural connections

Less than one hour of brain training with neurofeedback leads to a strengthening of neural connections and communication among brain areas.

15 Apr 2019

Improved gut diversity causes 50% reduction in autism symptoms

Changing the microbial environment in the gut in autistic children could substantially reduce the severity of the symptoms they experience, according to new research.

11 Apr 2019

Study sheds new light on long-term treatment with antidepressant drugs

A new study published in the current issue of Psychotherapy and Psychosomatics sheds new light on long-term studies with antidepressant drugs.

11 Apr 2019

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

Parkinson's disease affects between 7 and 10 million people worldwide and the number of people diagnosed is soaring due to the ageing population.

10 Apr 2019

$FDA approves new osteoporosis drug for postmenopausal women with high fracture risk$

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

9 Apr 2019

Acetaminophen can limit positive empathy for others, study shows

A new study by an Ohio University faculty member showed that acetaminophen limited positive empathy a person has for others while taking it.

8 Apr 2019

Anti-inflammatory medicine can be effective in treating people with depression

The World Health Organization calls depression one of the most serious mental disorders, and researchers around the world are trying to improve treatment of the disease.

8 Apr 2019

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

Researchers have known for decades that inflammation accompanies Alzheimer's disease brain lesions. Several early studies suggested that "super-aspirins" or Nonsteroidal anti-inflammatory drugs could help avoid the disease.

8 Apr 2019

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

Researchers have known for decades that inflammation accompanies Alzheimer's disease (AD) brain lesions.

5 Apr 2019

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

A potential new immune-based therapy to treat precancers in the cervix completely eliminated both the lesion and the underlying HPV infection in a third of women enrolled in a clinical trial.

4 Apr 2019

Gout treatment could potentially reduce complications accompanying metabolic syndrome

The drug colchicine, used to treat the arthritic condition gout, could potentially reduce complications accompanying metabolic syndrome, a combination of high blood pressure, high blood sugar and other conditions that increase the risk of heart disease and type 2 diabetes, according to researchers at the National Institutes of Health.

2 Apr 2019

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adults, to include relapsing-remitting disease and active secondary progressive disease.

29 Mar 2019

Placebo News and Research

Psychologists study how application of cortisol affects exposure therapy for anxiety disorders

Using blood thinners in heart failure patients associated with reduced risk of thromboembolic events

FDA authorizes marketing of first medical device to treat ADHD

Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients

Magic mouthwash effectively reduces mouth sore pain caused by radiation therapy

Drug lowers kidney failure risk in diabetic patients, study finds

Rheumatoid arthritis patients likely to experience cardiovascular benefits from statins

Brain training to strengthen the brain's neural network

Less than one hour of brain training leads to strengthening of neural connections

Improved gut diversity causes 50% reduction in autism symptoms

Study sheds new light on long-term treatment with antidepressant drugs

Innovative drug delivery may alleviate Parkinson's symptoms and stop its progression

FDA approves new osteoporosis drug for postmenopausal women with high fracture risk

Acetaminophen can limit positive empathy for others, study shows

Anti-inflammatory medicine can be effective in treating people with depression

New research finds anti-inflammatory drugs to be ineffective to prevent Alzheimer’s

NSAIDs ineffective for treatment or prevention of Alzheimer's disease

New immune-based therapy eliminates HPV in one-third of women with cervical precancerous lesions

Gout treatment could potentially reduce complications accompanying metabolic syndrome

FDA approves new oral drug to treat relapsing forms of multiple sclerosis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News